Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-02 @ 5:54 PM
Study NCT ID:
NCT03884192
Status:
UNKNOWN
Last Update Posted:
2019-03-21
First Post:
2019-01-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CONSIST
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None